Loeb & Loeb LLP is proud to sponsor the American Conference Institute's 7th Annual Summit on Biosimilars where partner Mark Waddell will be speaking on a panel titled, "Demystifying IPRs for Effective Use in the Biosimilars Landscape."
From conference website:
Based on industry demand, ACI is proud to bring you the leading event on biosimilars, comprised of industry insiders who are actively shaping the evolving U.S. biosimilars landscape. At this annual conference, the esteemed faculty will provide you with real-life strategies designed to meet the year’s biggest legal, regulatory, and IP challenges. Designed with input from the industry and the distinguished members of ACI’s Biosimilars Advisory Board, this year’s event features several new sessions aimed at giving you unique, up-to-the-minute information for biosimilars.